How states and localities spend opioid settlement dollars remains a slow health-budget fight as another reporting cycle lands. Billions from manufacturer and distributor deals are flowing, but trackers still find uneven use, hoarding, and disputes over treatment versus enforcement.

An Associated Press review of Maine localities found about $3 million spent last year from settlement shares, with spending choices varying widely by town and county — from treatment contracts to other local priorities. Shatterproof's national overview continues to flag transparency gaps: some governments publish dashboards and remediation plans; others sit on large balances or route money into criminal-justice accounts that addiction advocates say dilute abatement goals. In Michigan, the attorney general launched a settlement tracker after reporting that local governments were holding roughly $176 million unspent, turning hoarding into a statehouse accountability story.

National settlement architecture still rests on state-local splits, annual reports, and "opioid remediation" definitions that leave room for concerts, equipment, and other contested line items documented by health reporters. County budget offices like the flexible cash for staffing gaps; recovery groups want naloxone, inpatient beds, and housing first. Multi-year payment schedules mean the fight will not end with one audit season.

The practical question is whether 2026 reporting rules finally show treatment capacity rising — or whether the same transparency complaints recycle into another fiscal year. Accounts agree settlement cash is real and that tracking spending is now a policy beat. They differ on whether the bigger failure is slow local drawdown, weak transparency, or using funds for policing and other non-treatment priorities.